CureVac (CVAC)
(Delayed Data from NSDQ)
$3.29 USD
0.00 (0.00%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $3.30 +0.01 (0.30%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for CureVac NV falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -281.36 | -262.51 | -462.91 | -148.33 | NA |
Depreciation/Amortization & Depletion | 25.31 | 25.01 | 17.59 | 12.19 | NA |
Net Change from Assets/Liabilities | -73.91 | -132.29 | 26.91 | 697.00 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 40.03 | 68.27 | -404.32 | 35.88 | NA |
Net Cash From Operating Activities | -289.93 | -301.52 | -822.72 | 596.74 | NA |
Property & Equipment | -56.63 | -92.74 | -139.40 | -41.50 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | -0.29 | 0.00 | 0.00 | NA |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | -3.12 | -5.48 | -4.13 | -10.22 | NA |
Net Cash from Investing Activities | -59.74 | -98.51 | -143.53 | -51.72 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 255.52 | 71.01 | 418.75 | 991.19 | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -28.06 | -51.28 | NA |
Increase (Decrease) Short-Term Debt | -5.62 | -4.45 | -3.57 | -3.42 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Financing Activities | 249.90 | 66.56 | 387.12 | 936.50 | NA |
Effect of Exchange Rate Changes | -1.25 | 0.88 | 5.54 | -5.77 | NA |
Net Change In Cash & Equivalents | -101.03 | -332.59 | -573.59 | 1,475.75 | NA |
Cash at Beginning of Period | 536.60 | 854.96 | 1,484.21 | 35.05 | NA |
Cash at End of Period | 435.57 | 522.37 | 910.62 | 1,510.80 | NA |
Diluted Net EPS | -1.28 | -1.39 | -2.48 | -1.12 | NA |
Fiscal Year End for CureVac NV falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -151.98 | -75.88 | -281.36 | -188.82 | -136.09 |
Depreciation/Amortization & Depletion | 10.76 | 5.28 | 25.31 | 18.94 | 12.53 |
Net Change from Assets/Liabilities | -64.05 | -50.39 | -73.91 | -81.22 | -64.78 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 5.33 | 16.15 | 40.03 | 6.99 | 9.84 |
Net Cash From Operating Activities | -199.94 | -104.83 | -289.93 | -244.11 | -178.50 |
Property & Equipment | -9.14 | -5.51 | -56.63 | -41.56 | -29.68 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -4.40 | -0.02 | -3.12 | -2.84 | -0.16 |
Net Cash from Investing Activities | -13.54 | -5.52 | -59.74 | -44.40 | -29.84 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.15 | 0.10 | 255.52 | 257.15 | 257.38 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -2.67 | -1.32 | -5.62 | -4.32 | -2.75 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | -2.52 | -1.22 | 249.90 | 252.84 | 254.62 |
Effect of Exchange Rate Changes | 0.69 | 0.51 | -1.25 | 1.22 | -0.34 |
Net Change In Cash & Equivalents | -215.31 | -111.07 | -101.03 | -34.45 | 45.94 |
Cash at Beginning of Period | 433.40 | 436.94 | 536.60 | 539.63 | 540.62 |
Cash at End of Period | 218.09 | 325.88 | 435.57 | 505.18 | 586.55 |
Diluted Net EPS | -0.34 | -0.34 | -0.42 | -0.24 | -0.33 |